Linfu Chen
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Biotechnology top 2%
- Cancer Research and Treatments
Papers in
-
- Advanced Drug Delivery Systems 8
-
- Cancer Research and Treatments 6
- Co-authors
- Zhuang Liu (19 shared papers)Qian Chen (32 shared papers)Maoyi Li (8 shared papers)Qiufang Chen (2 shared papers)Ziliang Dong (1 shared paper)Jun Zhou (1 shared paper)Yang Yang (19 shared papers)Jingjing Shen (16 shared papers)
In The Last Decade
Linfu Chen
39 papers receiving 2k citations
Linfu Chen's Hit Papers
Peers
Comparison fields: 5 of 79
- Pharmaceutical Science 285
- Biotechnology 181
- Biomaterials 286
- Rehabilitation 109
- Food Science 260
Countries citing papers authored by Linfu Chen
This map shows the geographic impact of Linfu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfu Chen more than expected).
Fields of papers citing papers by Linfu Chen
This network shows the impact of papers produced by Linfu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfu Chen. The network helps show where Linfu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Linfu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery Hit paper breakdown → | 2022 | 564 |
| 2 | 2021 | 111 | |
| 3 | 2022 | 111 | |
| 4 | Bioactive Layered Double Hydroxides for Synergistic Sonodynamic/Cuproptosis Anticancer Therapy with Elicitation of the Immune Response Hit paper breakdown → | 2024 | 103 |
| 5 | 2023 | 91 | |
| 6 | 2023 | 88 | |
| 7 | 2021 | 84 | |
| 8 | 2022 | 70 | |
| 9 | 2023 | 70 | |
| 10 | Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery Hit paper breakdown → | 2024 | 67 |
| 11 | 2024 | 61 | |
| 12 | 2022 | 51 | |
| 13 | 2023 | 49 | |
| 14 | 2023 | 48 | |
| 15 | 2021 | 47 | |
| 16 | 2023 | 42 | |
| 17 | 2024 | 40 | |
| 18 | 2024 | 36 | |
| 19 | 2022 | 30 | |
| 20 | 2023 | 28 |
About Linfu Chen
Linfu Chen is a scholar working on Pharmaceutical Science, Biotechnology, Biomaterials, Immunology and Biomedical Engineering, having authored 41 papers that have together received 2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Advanced Drug Delivery Systems (8 papers), Immunotherapy and Immune Responses (7 papers), Nanoparticle-Based Drug Delivery (6 papers), Cancer Research and Treatments (6 papers), Inhalation and Respiratory Drug Delivery (4 papers), Retinal Diseases and Treatments (3 papers) and Inflammatory Bowel Disease (3 papers). The work is most often cited by research in Pharmaceutical Science (285 citations), Biotechnology (181 citations), Biomaterials (286 citations), Rehabilitation (109 citations) and Food Science (260 citations). Linfu Chen has collaborated with scholars based in China, Macao and Australia. Frequent co-authors include Zhuang Liu, Qian Chen, Maoyi Li, Qiufang Chen, Ziliang Dong, Jun Zhou, Yang Yang, Jingjing Shen, Nanhui Liu and Liang Cheng. Their work appears in journals such as Advanced Materials, ACS Nano, Science Advances, Nature Communications and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.